DOI: 10.1055/s-00000025

Hormone and Metabolic Research

Issue 09 · Volume 28 · September 1996 DOI: 10.1055/s-002-6641

Introduction

  • 403
    Matthews, David R.; Riddle, Matthew C.:

    Introduction

    • Overview

  • 404
    Gerich, J. E.:

    Pathogenesis and Treatment of Type 2 (Noninsulin-Dependent) Diabetes Mellitus (NIDDM)

    • Clinical

  • 413
    Schneider, J.:

    An Overview of the Safety and Tolerance of Glimepiride

  • 419
    Draeger, K. E.; Wernicke-Panten, K.; Lomp, H.-J.; Schüler, E.; Roßkamp, R.:

    Long-Term Treatment of Type 2 Diabetic Patients with the New Oral Antidiabetic Agent Glimepiride (Amaryl®): A Double-Blind Comparison with Glibenclamide

  • 426
    Dills, Diana G.; Schneider, Jill; The Glimepiride/Glyburide Research Group:

    Clinical Evaluation of Glimepiride versus Glyburide in NIDDM in a Double-Blind Comparative Study

  • 430
    Riddle, M. C.:

    Combined Therapy With a Sulfonylurea Plus Evening Insulin: Safe, Reliable, and Becoming Routine

  • 434
    Rosenkranz, B.:

    Pharmacokinetic Basis for the Safety of Glimepiride in Risk Groups of NIDDM Patients

    • Tissue Sensitivity

  • 440
    Karam, J. H.:

    Reversible Insulin Resistance in Non-Insulin-Dependent Diabetes Mellitus

  • 445
    Clark, H. E.; Matthews, D. R.:

    The Effect of Glimepiride on Pancreatic β-Cell Function Under Hyperglycaemic Clamp and Hyperinsulinaemic, Euglycaemic Clamp Conditions in Non-Insulin-Dependent Diabetes Mellitus

  • 451
    Massi-Benedetti, M.; Herz, M.; Pfeiffer, Claudia:

    The Effects of Acute Exercise on Metabolic Control in Type II Diabetic Patients Treated with Glimepiride or Glibenclamide

    • Mechanisms

  • 456
    Ashcroft, Frances M.:

    Mechanisms of the Glycaemic Effects of Sulfonylureas

  • 464
    Kramer, W.; Müller, G.; Geisen, K.:

    Characterization of the Molecular Mode of Action of the Sulfonylurea, Glimepiride, at β-Cells

  • 469
    Müller, G.; Geisen, K.:

    Characterization of the Molecular Mode of Action of the Sulfonylurea, Glimepiride, at Adipocytes

  • 488
    Lazdunski, M.:

    Ion Channel Effects of Antidiabetic Sulfonylureas

    • CV-Effect

  • 496
    Geisen, K.; Végh, Agnes; Krause, E.; Papp, J. C.:

    Cardiovascular Effects of Conventional Sulfonylureas and Glimepiride

  • 508
    Eckel, J.:

    Direct Effects of Glimepiride on Protein Expression of Cardiac Glucose Transporters

  • 512
    Bijlstra, P. J.; Russel, F. G. M.; Thien, T.; Lutterman, J. A.; Smits, P.:

    Effects of Tolbutamide on Vascular ATP-Sensitive Potassium Channels in Humans

    • Debate

  • 517
    Waldhäusl, W.:

    Role of Sulfonylureas in Non-Insulin-Dependent Diabetes Mellitus: Part I - “The pros”

  • 522
    Heine, R. J.:

    Role of Sulfonylureas in Non-Insulin-Dependent Diabetes Mellitus: Part II - “The cons”